GMO Beyond China ETF (BCHI) seeks to provide exposure to emerging and developed markets while excluding Chinese companies and China-related investments. This geographic exclusion strategy targets international diversification for investors wanting global equity exposure without China's specific political, regulatory, and economic risks.
How It Works
BCHI employs an actively managed approach that screens out Chinese companies, Hong Kong-listed Chinese firms, and businesses with significant China revenue exposure from its investment universe. The fund likely uses fundamental analysis to select stocks across developed and emerging markets outside China, with portfolio construction based on GMO's proprietary research and valuation models. Rebalancing occurs as needed based on market conditions and company fundamentals rather than fixed schedules.
Key Features
- Unique China exclusion strategy addresses growing geopolitical concerns while maintaining broad international market exposure
- Actively managed by GMO, known for contrarian value investing and rigorous fundamental research methodology
- Recently launched fund with 2.06% dividend yield providing income alongside international equity growth potential
Risks
- This ETF can lose value if excluded Chinese markets significantly outperform, potentially missing 30-40% of emerging market returns during China rallies
- Active management risk means fund performance depends heavily on GMO's stock selection skills and market timing decisions
- International equity volatility could cause 20-30% declines during global market downturns, amplified by currency fluctuations against the dollar
Who Should Own This
Best suited for investors with 3-7 year time horizons seeking international diversification without China exposure as a satellite holding (10-25% of equity allocation). Medium-to-high risk tolerance required for international equity volatility. Ideal for those concerned about Chinese regulatory risks or seeking geopolitical diversification in their global portfolio.